enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Apixaban - Wikipedia

   en.wikipedia.org/wiki/Apixaban

   Apixaban is recommended by the National Institute for Health and Clinical Excellence for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation and at least one of the following risk factors: prior stroke or transient ischemic attack, age 75 years or older, diabetes, or symptomatic heart failure. [17]

3. Is Eliquis Covered by Medicare? - AOL

   www.aol.com/eliquis-covered-medicare-140000963.html

   According to the manufacturer of Eliquis, in 2024, the list price for a 30-day supply of Eliquis is $594, but people on Medicare pay, on average, $55 per month. And 5 out of 10 people on Medicare ...

4. Biden targets diabetes drug Jardiance, blood thinner Eliquis ...

   www.aol.com/finance/biden-targets-diabetes-drug...

   About 9% of Medicare beneficiaries age 65 and older said in 2021 that they did not fill a prescription or skipped a drug dose due to cost, according to research by the Commonwealth Fund, which ...

5. U.S. FDA Approves ELIQUIS® (apixaban) to Reduce the ... - AOL

   www.aol.com/news/2013-01-02-us-fda-approves...

   U.S. FDA Approves ELIQUIS ® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation ELIQUIS Demonstrated Superior Risk Reductions Versus ...

6. CHA2DS2–VASc score - Wikipedia

   en.wikipedia.org/wiki/CHA2DS2–VASc_score

   Thus, the CHA 2 DS 2-VASc score is a refinement of CHADS 2 [8] [10] score and extends the latter by including additional common stroke risk factors, that is, age 65–74, female gender and vascular disease. [11] In the CHA 2 DS 2-VASc score, 'age 75 and above' also has extra weight, with 2 points.

7. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   The monitoring of warfarin and keeping the international normalized ratio (INR) between 2.0 and 3.0, along with avoiding over and under treatment, has driven a search for an alternative. [3] [14] A naturally occurring inhibitor of factor Xa was reported in 1971 by Spellman et al. from the dog hookworm. [15]